Sputum-to-serum hydrogen sulphide ratio as a novel biomarker of predicting future risks of asthma exacerbation
Clinical & Experimental Allergy Jun 17, 2018
Suzuki Y, et al. - Researchers examined the link between hydrogen sulphide (H2S) levels and disease activity in asthma by investigating possible variations in H2S levels during different conditions in asthma. Stable asthmatic subjects (S-BA), uncontrolled asthmatic subjects (UC-BA), asthmatic subjects with acute exacerbation (AE-BA) and healthy subjects were examined. Significantly higher sputum H2S levels were detected in the AE-BA subjects vs the UC-BA and healthy subjects. The AE-BA subjects had lower serum H2S levels, compared with the S-BA subjects, while these levels were similar to those in healthy subjects. Overall, H2S ratio may have utility in the prediction of future risks of asthma exacerbation. It may offer useful information on obstructive neutrophilic airway inflammation as one of the non-Th2 biomarkers, in asthma.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries